Literature DB >> 6183566

The effect of poly I:C and IUDR on the inhibition of HSV in rabbit eyes.

O Smetana, E Eylan, N Kariv.   

Abstract

The inhibition of herpetic keratitis by a combination of Poly I:C with DEAE-Dextran and IUDR was studied in rabbit eyes. This treatment was administered 72 h after HSV inoculation (daily) for 3 days and continued once daily for another 2-3 days. A significant improvement was detected in rabbit eyes beginning on the first day of treatment, and there was minimal scarring. This improvement in herpetic keratitis coincided with a decrease in the virus titer isolated from rabbit eyes and an increase in interferon titer detected in rabbit tears. The cornea and trigeminal ganglia of treated and control rabbits were tested in order to prove whether this combined treatment could inhibit the migration of HSV from the cornea to the trigeminal ganglia. During the active stage of the disease, HSV was isolated in a lower titer from the cornea of the treated rabbits and from the ganglia of only half of this rabbit group. During the latent stage of the disease, no HSV was isolated from the cornea of either rabbit group, but HSV was isolated from the ganglia explants of the treated rabbits in a somewhat lower titer than from the controls. This treatment administered 3 days after the virus inoculation could not prevent the migration of HSV from the infected cornea towards the trigeminal ganglia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183566     DOI: 10.1007/bf02124917

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  31 in total

1.  Radioimmunoassay of herpes simplex virus antibody: correlation with ganglionic infection.

Authors:  B Forghani; T Klassen; J R Baringer
Journal:  J Gen Virol       Date:  1977-09       Impact factor: 3.891

2.  Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.

Authors:  A S Levine; M Sivulich; P H Wiernik; H B Levy
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

3.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

4.  Prophylaxis of herpetic keratoconjunctivitis with interferon inducers. Preliminary observations.

Authors:  J H Park; M A Galin; A Billau; S Baron
Journal:  Arch Ophthalmol       Date:  1969-06

5.  The chronology of primary herpes simplex infection of the eye and adnexal glands.

Authors:  D Pavan-Langston; A B Nesburn
Journal:  Arch Ophthalmol       Date:  1968-08

6.  Interferon and residual In.Cn in rabbit eyes following topical or subconjunctival application of the polynucleotide.

Authors:  L Sawicki; E Chowchuvech; M Weissenbacher; M A Galin
Journal:  Can J Ophthalmol       Date:  1973-10       Impact factor: 1.882

7.  Intraocular production of interferon.

Authors:  M Weissenbacher; N Schachter; M A Galin; S Baron
Journal:  Arch Ophthalmol       Date:  1970-10

8.  Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

9.  Therapeutic use of inducers of interferon on Herpes simplex keratitis in humans.

Authors:  M A Galin; E Chowchuvech; B Kronenberg
Journal:  Ann Ophthalmol       Date:  1976-01

10.  Pharmacologic effects of polyinosinic-polycytidylic acid in man.

Authors:  A I Freeman; N Al-Bussam; J A O'Malley; L Stutzman; S Bjornsson; W A Carter
Journal:  J Med Virol       Date:  1977       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.